The DU145 prostate cancer cell line expresses an autocrine IL-6 signaling loop [41] and was recently reported to be sensitive to the effects of a novel small molecule JAK2 inhibitor in vitro and in vivo[3], [41]. This evidence concerns the gene IL6 and prostate cancer.